These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37292207)

  • 1. Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression.
    Zhong S; Yin Y
    Front Immunol; 2023; 14():1183542. PubMed ID: 37292207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R; Zhou L
    Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding the potential role of regulatory T cells in sepsis-induced immunosuppression.
    Huang S; Liu D; Han L; Deng J; Wang Z; Jiang J; Zeng L
    Eur J Immunol; 2024 May; 54(5):e2350730. PubMed ID: 38430202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publication trends of research on sepsis and programmed cell death during 2002-2022: A 20-year bibliometric analysis.
    Li JY; Yao RQ; Xie MY; Zhou QY; Zhao PY; Tian YP; Yao YM
    Front Cell Infect Microbiol; 2022; 12():999569. PubMed ID: 36211966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
    He X; Bo L; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options.
    Pei F; Gu B; Miao SM; Guan XD; Wu JF
    Chin J Traumatol; 2024 Mar; 27(2):63-70. PubMed ID: 38040590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in programmed death-1 signaling pathway in sepsis].
    Xu C; Li L; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1160-1162. PubMed ID: 31657345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch Signaling Pathway Was Involved in Regulating Programmed Cell Death 1 Expression during Sepsis-Induced Immunosuppression.
    Pan T; Liu Z; Yin J; Zhou T; Liu J; Qu H
    Mediators Inflamm; 2015; 2015():539841. PubMed ID: 26063974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
    Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
    Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in immunotherapeutic research of sepsis].
    Dong L; Lyu J; Ding L; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):184-187. PubMed ID: 28625271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike.
    Watanabe E; Thampy LK; Hotchkiss RS
    Acute Med Surg; 2018 Oct; 5(4):309-315. PubMed ID: 30338075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the host response in sepsis: current approaches and future evidence.
    Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
    Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.
    Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L
    Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction.
    Liu AB; Li SJ; Yu YY; Zhang JF; Ma L
    Front Cell Dev Biol; 2023; 11():1309719. PubMed ID: 38161332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tong‑fu‑li‑fei decoction attenuates immunosuppression to protect the intestinal‑mucosal barrier in sepsis by inhibiting the PD‑1/PD‑L1 signaling pathway.
    Chen L; Li L; Zou S; Liao Q; Lv B
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34633052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.
    Wakeley ME; Gray CC; Monaghan SF; Heffernan DS; Ayala A
    Crit Care Clin; 2020 Jan; 36(1):69-88. PubMed ID: 31733683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.